Anti-Recombinant-YTHDF1 antibody [RM2N97] (STJA0026259)

SKU:
STJA0026259
£300.50 - £457.50
Free Shipping
Processing The item has been added

Short Description :Rabbit monoclonal anti-Recombinant-YTHDF1 for use in IP and WB in Human and Hamster samples. Datasheet included with dilution recommendations, and related reagents.
Applications:IP/WB
Host:Rabbit
Reactivity:Human/Hamster
Note:STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Clonality :Monoclonal
Clone ID :RM2N97
Isotype:IgG
Conjugation:Unconjugated
Purification:Protein A/G purified from cell culture supernatant
Dilution Range:IP: 1:20, WB: 1:500-1:1000
Formulation:0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium Azide
Storage Instruction:Suitable for storage at +4°C between 1-2 weeks. For longer term store at-20°C for up to 12 months.
Gene Symbol:Ythdf1
Gene ID:228994
Uniprot ID:YTHD1_MOUSE
Post Translational Modifications Ubiquitinated by the CUL7-FBXW8 E3 ligase complex leading to degradation. Deubiquitinated and stabilized by USP5 by removing 'Lys-11'-linked polyubiquitination.
Function Specifically recognizes and binds N6-methyladenosine (m6A)-containing mRNAs, and regulates their stability. M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in mRNA stability and processing. Acts as a regulator of mRNA stability by promoting degradation of m6A-containing mRNAs via interaction with the CCR4-NOT complex. The YTHDF paralogs (YTHDF1, YTHDF2 and YTHDF3) share m6A-containing mRNAs targets and act redundantly to mediate mRNA degradation and cellular differentiation. Required to facilitate learning and memory formation in the hippocampus by binding to m6A-containing neuronal mRNAs. Acts as a regulator of axon guidance by binding to m6A-containing ROBO3 transcripts. Acts as a negative regulator of antigen cross-presentation in myeloid dendritic cells. In the context of tumorigenesis, negative regulation of antigen cross-presentation limits the anti-tumor response by reducing efficiency of tumor-antigen cross-presentation. Promotes formation of phase-separated membraneless compartments, such as P-bodies or stress granules, by undergoing liquid-liquid phase separation upon binding to mRNAs containing multiple m6A-modified residues: polymethylated mRNAs act as a multivalent scaffold for the binding of YTHDF proteins, juxtaposing their disordered regions and thereby leading to phase separation. The resulting mRNA-YTHDF complexes then partition into different endogenous phase-separated membraneless compartments, such as P-bodies, stress granules or neuronal RNA granules.
Protein Name Yth Domain-Containing Family Protein 1
Dermatomyositis Associated With Cancer Putative Autoantigen 1 Homolog
Daca-1 Homolog
Database Links
Cellular Localisation Cytoplasm
P-Body
Stress Granule
Alternative Antibody Names Anti-Yth Domain-Containing Family Protein 1 antibody
Anti-Dermatomyositis Associated With Cancer Putative Autoantigen 1 Homolog antibody
Anti-Daca-1 Homolog antibody
Anti-Ythdf1 antibody

Information sourced from Uniprot.org